Weekly Executive & Director Moves (July 8)

by | Jul 8, 2022

Boardroom Alpha provides in-depth analytics and tracking of all public company executives and officers. Below is a rundown of people moves made at notable companies this past week. Get a demo today to see how you can receive real-time alerts and in-depth analytics.

Highlights

Light week of exec moves this week following a very active prior week, which makes sense as Q2 was coming to close. Some highlights for this week include:

  • AllianceBernstein (AB) announced that COO Kate Burke would be adding CFO to her responsibilities following the departure of previous CFO Ali Dibadj in March. Bill Siemers had been interim CFO
  • The merger of Whiting & Oasis Petroleum closed, resulting in Chord Energy (CHRD). 5 directors from Whiting joined 5 directors from Oasis to makeup the board
  • Connor Schell, who spent years at ESPN running content across multiple disciples, resigned from the board of World Wrestling Entertainment Inc. (WWE). Vince McMahon resigned as CEO last month due to a sexual conduct investigation.

Moves in this Issue

CEO

EPM, FITB

CFO

AB, AC, BIOL, BK

Directors

AAMC, ADGI, ALE, APEN, ATER, BOX, BTTX, CCXI, CERS, CHRD, CNTA, CODI, CTRE, DINO, EBS, EE, ELOX, GH, HFFG, JBI, LIXT, LOTZ, LOVE, MATV, PASG, PEAK, RGTI, SCOR, TRU, TSCO, TW, UFI, VEC, VEEE, WAB, WWE


CEO Moves

EVOLUTION PETROLEUM CORP (EPM)
Leaving: CEO – Jason E Brown ( 3.0 yrs; 3.8% TSR)
Replaced by: Kelly William Loyd

Mr. Loyd, 48, has been a director of the Company since 2008 and currently chairs the Investment Committee of the Board. Since 2004, Mr. Loyd has been associated with Petralis Energy Partners, LLC and JVL Advisors, LLC, both being private energy investment vehicles. From 2001 to 2004, Mr. Loyd was an associate in the energy corporate finance investment banking group at RBC Capital Markets and Howar…read full bio

FIFTH THIRD BANCORP (FITB)
Leaving: CEO – Greg D Carmichael ( 6.7 yrs; 13.0% TSR)
Replaced by: Timothy Spence

Mr. Spence currently serves as President of Fifth Third Bancorp and Executive Vice President of Fifth Third Bank, National Association. Mr. Spence will succeed Greg D. Carmichael as Chief Executive Officer. Upon his retirement as Chief Executive Officer effective July 5, 2022, Mr. Carmichael will become the Executive Chairman of the Boards of Directors of Fifth Third Bancorp and Fifth Third Bank, …read full bio

CFO Moves

ALLIANCEBERNSTEIN HOLDING LP (AB)
Leaving: CFO – William R Siemers ( .3 yrs; )
Replaced by: Kate C Burke

Kate C. Burke, Chief Administrative Officer Ms. Burke, age 48, was appointed Chief Administrative Officer in May 2019. Previously, she served as Head of Human Capital and Chief Talent Officer from February 2016 to May 2019. She joined our firm in 2004 as an institutional equity salesperson with Bernstein Research Services and has held various managerial roles since that time. Prior to joining AB, …read full bio

BANK OF NEW YORK MELLON CORP (BK)
Leaving: CFO – Emily Hope Portney ( 2.5 yrs; 7.5% TSR)
Replaced by: Dermot McDonogh

Mr. McDonogh, 57, most recently served as the chief operating officer of the Europe, Middle East, and Africa region for Goldman Sachs International and as the chief executive officer of Goldman Sachs International Bank since 2015.

As CFO, Mr. McDonogh’s responsibilities will span global financial strategy and financial operations, including fin…read full bio

BIOLASE INC (BIOL)
Leaving: CFO – John R Beaver ( 4.8 yrs; -43.6% TSR)
Replaced by: Jennifer Bright

Ms. Bright will receive an annual salary of $285,000 in consideration for her service as Chief Financial Officer of the Company, and will be eligible for a bonus compensation target of fifty percent (50%) of annual salary, subject to criteria as established by the Compensation Committee of the Board (the “Compensation Committee”). Ms. Bright’s employment with the Company is at-will. From April 202…read full bio

Director Joins

ADAGIO THERAPEUTICS INC (ADGI)
David Hering

David Hering, M.B.A. has served as our Interim Chief Executive Officer since February 2022 and as Chief Operating Officer since June 2021. Prior to joining Adagio, Mr. Hering served as the Head of the mRNA Global Franchise Business of Pfizer, Inc., a pharmaceutical company, from April 2021 to June 2…read full bio

ALLETE INC (ALE)
Charles R Matthews

Mr. Matthews served as the president of Peoples Energy, LLC and as the president and chief executive officer of both The Peoples Gas Light and Coke Company and North Shore Gas Company, each of which is a subsidiary of WEC Energy Group Inc. (NYSE:WEC), from June 2015 until his retirement on July…read full bio

ALTISOURCE ASSET MANAGEMENT CORP (AAMC)
Jason A Kopcak

Prior to joining the Company, Mr. Kopcak, 50, was employed with Morgan Stanley beginning in September, 2018, as an Executive Director of the residential mortgage team within Global Capital Markets. He was involved in all facets of the …read full bio

APOLLO ENDOSURGERY INC (APEN)
Sharon O’Keefe

Ms. O’Keefe was President of the University of Chicago Medical Center from 2011 to 2020, overseeing a network of physicians and clinics with 10,000 employees and annual operating revenue in excess of $2 billion. Previously, Ms. O’Keefe served in executive leadership roles at L…read full bio

BETTER THERAPEUTICS INC (BTTX)
Frank Karbe

Mr. Karbe, 54, previously served as the Principal Financial and Accounting Officer of Myovant Sciences Ltd. from September 2016 to August 2021. Mr. Karbe was appointed as Myovant Sciences, Inc.’s Chief Financial Officer in April 2017 and was subsequently appointed as President and…read full bio

CARETRUST REIT INC (CTRE)
David M Sedgwick

David M. Sedgwick has served as our Chief Executive Officer since January 2022 and as our President since February 2021. He previously served as our Chief Operating Officer from August 2018 through 2021, and as our Vice President-Operations from our formation in 2014 through August 2018. He is a lic…read full bio

CENTESSA PHARMACEUTICALS PLC (CNTA)
Mathias Hukkelhoven

Dr. Hukkelhoven was also appointed as a member of the Nominating and Governance Committee of the Board. Dr. Hukkelhoven is an experienced global regulatory and drug development leader. He previously served as Senior Vice President, Global Regulatory, Safety & Biometrics at Bristol Myers Squibb (“BMS…read full bio

CERUS CORP (CERS)
Hua Shan

Prior to her roles at Stanford, Dr. Shan served as the Medical Director of the Blood Bank Service and as the Associate Director of Transfusion Medicine at Johns Hopkins University, Assistant Medical Director at Medical University of South Carolina and Transfusion Medicine Fellow at the Unive…read full bio

CHEMOCENTRYX INC (CCXI)
Jennifer Lyn Herron

Ms. Herron was appointed to serve as a Class I director, with an initial term expiring at the 2024 annual meeting of stockholders of the Company. Ms. Herron has served as Senior Vice President and Chief Commercial Officer of ADC Therapeutics since November 2019. Before joining ADC Therapeutics, Ms. …read full bio

CHORD ENERGY CORP (CHRD)
Kevin S McCarthy

Kevin S. McCarthy has been Chairman of the Board of Whiting Petroleum Corporation since September 2020. Mr. McCarthy has served as Vice Chairman at Kayne Anderson Capital Advisors, L.P. (“Kayne Anderson”) since 2019 and was Chairman of the Board for Kayne Anderson’s&nb…read full bio

CHORD ENERGY CORP (CHRD)
Susan M Cunningham

Susan M. Cunningham has been a director of Whiting Petroleum Corporation since September 2020. From 2017 to 2019, Ms. Cunningham served as an Advisor for Darcy Partners, a consulting firm. Ms. Cunningham served as Executive Vice President, EHSR and New Frontiers, for Noble Energy, Inc. from 2014 …read full bio

CHORD ENERGY CORP (CHRD)
Paul Korus

Paul J. Korus has been a director of Whiting Petroleum Corporation since September 2020. Mr. Korus was the Senior Vice President, Chief Financial Officer of Cimarex Energy Co. from 2002 until his retirement in 2015, and held the same positions with its predecessor, Key Production Compan…read full bio

CHORD ENERGY CORP (CHRD)
Anne Taylor

Anne Taylor has been a director of Whiting Petroleum Corporation since September 2020. Ms. Taylor is the President and sole owner of AT Strategies LLC, a consulting firm providing executive coaching services. Ms. Taylor retired in 2018 from Deloitte LLP (“Deloitte”…read full bio

CHORD ENERGY CORP (CHRD)
Lynn A Peterson

Lynn A. Peterson has been the President and Chief Executive Officer and a director of Whiting Petroleum Corporation since September 2020. Prior to joining Whiting, Mr. Peterson was the Chairman of the Board, Chief Executive Officer and President of SRC Energy Inc. from May 2015 to …read full bio

COMPASS DIVERSIFIED HOLDINGS (CODI)
Teri Shaffer

Shaffer has more than 38 years of finance and accounting experience. She served as the Americas and Regional Financial Audit IT Leader for Ernst & Young from 2016 through her recent retirement on July 1, 2022, and served in various other leadership roles at Ernst & Young since 198…read full bio

EXCELERATE ENERGY INC (EE)
Deborah L Byers

Ms. Byers recently retired as a Partner from Ernst & Young LLP (“EY”) and brings 36 years of Public Accounting experience to the Excelerate Energy Board. During her tenure at EY, Ms. Byers held multiple leadership roles, including serving as EY’s Americas Industry Lead…read full bio

GUARDANT HEALTH INC (GH)
Steve E Krognes

Mr. Krognes will serve on the Board for a term expiring at the 2024 Annual Meeting of Stockholders and until his successor is duly elected and qualified, or until his earlier death, resignation or removal. In connection with his appointment to the Board, Mr. Krognes was appointed to the audit commit…read full bio

HF FOODS GROUP INC (HFFG)
Jose Maroto

Mr. Maroto’s experience spans across Latin America. He started and grew businesses in Costa Rica and Panama which became the largest foodservice distributors in each country. In addition, he built foodservice cash and carry retail businesses in both Costa Rica and Panama, which curr…read full bio

HF SINCLAIR CORP (DINO)
Rhoman J Hardy

Mr. Hardy, 53, joined Shell USA, Inc. (formerly Shell Oil Company, Inc.) in 1988, and at the time of his retirement in 2022, Mr. Hardy served as Senior Vice President, Shell Chemicals and Products, for the U.S. Gulf Coast, a position he held since 2021. Prior to that time, Mr. Hardy served in a…read full bio

JANUS INTERNATIONAL GROUP INC (JBI)
Heather Harding

Heather Harding, age 53, previously served as Chief Financial Officer of Luxfer Holdings PLC from January 1, 2018 until March 1, 2022 and will serve as an Advisor to the CEO through December 2022. Over the past 25 years, Ms. Harding has held finance leadership roles of increasing r…read full bio

LOVESAC CO (LOVE)
Vineet Mehra

Vineet Mehra currently serves as Chief Marketing Officer of Chime, a financial technology company, where he oversees Chime’s growth initiatives across the U.S. in addition to developing impactful marketing and advertising initiatives. He was named by Forbes as one of the wor…read full bio

PASSAGE BIO INC (PASG)
Michael E Kamarck

Dr. Kamarck is the Chairman of the Sanofi Biotech Advisory Council, a position held since 2014, and a member of the board of directors of Vaxcyte, Inc., a position held since 2021. He recently retired as Chief Technology Officer for Vir Biotechnology, Inc., where he served from 2017 to 2021. Dr. Kam…read full bio

TRADEWEB MARKETS INC (TW)
Rana Yared

Ms. Yared is a General Partner at Balderton Capital, a leading venture capital investor focused on European founders with global ambitions from seed to exit. She joined Balderton in 2020 following 14 years at Goldman Sachs, where she was a Partner in the Principal Strategic Investments Group and lat…read full bio

TRADEWEB MARKETS INC (TW)
Jacques Aigrain

Mr. Aigrain and Ms. Yared were each designated to serve on the Board by Refinitiv Parent Limited (“Refinitiv”), our controlling stockholder, pursuant to Refinitiv’s director designation right as set forth in Section 2.1 of that certain Stockholders Agreement, dated as of April 8, 2019, by and among …read full bio

TRANSUNION (TRU)
Hamidou Dia

Dia, 57, has served as VP and Global Head of Solutions Engineering at Google Cloud since April 2019, where he leads the Global Solution Engineering organization. He is also a member of the Go-To-Market Advisory Board for CapitalG, Alphabet’s Independent Growth Fund.read full bio

TWIN VEE POWERCATS CO (VEEE)
Kevin Schuyler

Mr. Schuyler, age 53, currently serves as a senior managing director at CornerStone Partners, a full-service institutional CIO and investment office located in Charlottesville, VA, with approximately $10 billion under management. Prior to joining CornerStone Partners in 2006, he held various posi…read full bio

Director Exits

APOLLO ENDOSURGERY INC (APEN)
Rick D Anderson ( 8.8 yrs; -41.8% TSR)
Committees: Nominating (and Governance)

ATERIAN INC (ATER)
Amy Von Walter ( 3.1 yrs; -29.4% TSR)
Committees: Audit, Compensation

BOX INC (BOX)
Kimberly Hammonds ( 3.7 yrs; 1.4% TSR)
Committees: Audit, Nominating (and Governance), Operating

CARETRUST REIT INC (CTRE)
Gregory K Stapley ( 9.4 yrs; 8.3% TSR)

CARLOTZ INC (LOTZ)
Sarah M Kauss ( 1.5 yrs; -85.9% TSR)
Committees: Audit, Compensation

CENTESSA PHARMACEUTICALS PLC (CNTA)
Aaron Kantoff ( 1.2 yrs; -74.3% TSR)

COMSCORE INC (SCOR)
Irwin Gotlieb ( 3.3 yrs; -51.1% TSR)

ELOXX PHARMACEUTICALS INC (ELOX)
Zafrira Avnur ( 4.5 yrs; -49.0% TSR)
Committees: Compensation, Nominating (and Governance)

ELOXX PHARMACEUTICALS INC (ELOX)
Jasbir Seehra ( 4.3 yrs; -52.9% TSR)
Committees: Audit, Compensation

ELOXX PHARMACEUTICALS INC (ELOX)
Gadi Veinrib ( 4.5 yrs; -49.0% TSR)
Committees: Compensation

ELOXX PHARMACEUTICALS INC (ELOX)
Ran Nussbaum ( 4.5 yrs; -49.0% TSR)
Committees: Nominating (and Governance), Strategic Finance

ELOXX PHARMACEUTICALS INC (ELOX)
Rajesh R Parekh ( 1.2 yrs; -87.1% TSR)

HEALTHPEAK PROPERTIES INC (PEAK)
Lydia H Kennard ( 4.2 yrs; 7.8% TSR)
Committees: Audit, Compensation

LIXTE BIOTECHNOLOGY HOLDINGS INC (LIXT)
Philip F Palmedo ( .1% TSR)

RIGETTI COMPUTING INC (RGTI)
Peter Pace ( .3 yrs; )

UNIFI INC (UFI)
James M Kilts ( 6.3 yrs; -7.7% TSR)
Committees: Compensation

WORLD WRESTLING ENTERTAINMENT INC (WWE)
Connor Schell ( 1.2 yrs; 11.2% TSR)

<a href="https://www.boardroomalpha.com/author/draps/" target="_self">David Drapkin</a>

David Drapkin

Spent his formative years at Goldman Sachs and now embraces the start-up life in NYC. A long suffering Oakland (Las Vegas) Raiders fan and graduate of the Wharton School at the University of Pennsylvania. Semi-professional go-kart racer waiting for his shot.

More from Boardroom Alpha

SPAC Daily: Tuesday 9/14

Maxpro Acquisition (JMAC) penned the lone SPAC DA of the day, plus the rest of today’s news in the market.

SPAC Daily: A Merger Monday

4 new SPAC deals to get the week started, a new SPAC for dMY plus of the rest of the day’s SPAC market news.

Know Who Drives Return

Objective, data-driven assessments for every public company director and officer.

Disclaimer

The opinions and information contained herein have been obtained or derived from sources believed to be reliable, but Boardroom Alpha cannot guarantee its accuracy and completeness, and that of the opinions based thereon. 

This report contains opinions and is provided for informational purposes only – it does not constitute investment, legal or tax advice. You should not rely solely upon the research herein for purposes of transacting securities or other investments, and you are encouraged to conduct your own research and due diligence, and to seek the advice of a qualified securities professional before you make any investment.  

None of the information contained in this report constitutes, or is intended to constitute a recommendation by Boardroom Alpha of any particular security or trading strategy or a determination by BA that any security or trading strategy is suitable for any specific person. To the extent any of the information contained herein may be deemed to be investment advice, such information is impersonal and not tailored to the investment needs of any specific person.  

No representation or warranty, expressed or implied, is made on behalf of Boardroom Alpha as to the accuracy or completeness of the information contained herein. Boardroom Alpha does not accept any liability for any direct, indirect or consequential loss or damage suffered by any person as a result of relying on all or any part of this research and any liability is expressly disclaimed. 

Executive Moves

Newsletter

Get it in your inbox weekly and don't miss a move